FR2181687B1 - - Google Patents

Info

Publication number
FR2181687B1
FR2181687B1 FR7302472A FR7302472A FR2181687B1 FR 2181687 B1 FR2181687 B1 FR 2181687B1 FR 7302472 A FR7302472 A FR 7302472A FR 7302472 A FR7302472 A FR 7302472A FR 2181687 B1 FR2181687 B1 FR 2181687B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7302472A
Other versions
FR2181687A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2181687A1 publication Critical patent/FR2181687A1/fr
Application granted granted Critical
Publication of FR2181687B1 publication Critical patent/FR2181687B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7302472A 1972-01-25 1973-01-24 Expired FR2181687B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US220697A US3905963A (en) 1972-01-25 1972-01-25 Process for preparing primary 3-carbamoyloxymethyl cephalosporins

Publications (2)

Publication Number Publication Date
FR2181687A1 FR2181687A1 (fr) 1973-12-07
FR2181687B1 true FR2181687B1 (fr) 1976-07-02

Family

ID=22824586

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7302472A Expired FR2181687B1 (fr) 1972-01-25 1973-01-24

Country Status (24)

Country Link
US (1) US3905963A (fr)
JP (1) JPS5538956B2 (fr)
AR (1) AR196324A1 (fr)
AT (1) AT325764B (fr)
AU (1) AU465060B2 (fr)
BE (1) BE794389A (fr)
BG (1) BG22403A3 (fr)
CA (1) CA1014548A (fr)
CH (1) CH567513A5 (fr)
CS (1) CS192502B2 (fr)
DD (1) DD103246A5 (fr)
DE (1) DE2303022C2 (fr)
ES (1) ES410946A1 (fr)
FR (1) FR2181687B1 (fr)
GB (1) GB1409633A (fr)
HU (1) HU170132B (fr)
IE (1) IE37138B1 (fr)
IL (1) IL41310A (fr)
NL (1) NL7301038A (fr)
PL (1) PL83446B1 (fr)
RO (1) RO62820A (fr)
SE (1) SE418293B (fr)
YU (1) YU36973B (fr)
ZA (1) ZA73320B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173703A (en) * 1971-12-14 1979-11-06 Merck & Co., Inc. Preparation of carbamates
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
US4198503A (en) * 1974-11-05 1980-04-15 Beecham Group Limited 3-Carbamoyl substituted-7-ureido substituted cephalosporins
US4121041A (en) * 1977-02-04 1978-10-17 Merck & Co., Inc. 7-(Amidinothio)acetamido-7-methoxy cephalosporins
CA1128930A (fr) * 1978-04-07 1982-08-03 Stuart B. Laing Cephalosporine
ES8101607A1 (es) * 1979-02-15 1980-12-16 Glaxo Group Ltd Un procedimiento para la preparacion de cefuroxima sodica o un solvato de la misma
CA1178489A (fr) * 1981-11-10 1984-11-27 Roy A. Young Coupe-bise
CN110204557B (zh) * 2019-07-02 2021-08-20 苏州盛达药业有限公司 一种头孢孟多酯钠衍生物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445633A1 (de) * 1963-10-07 1968-12-05 Ciba Geigy Verfahren zur Herstellung neuer Amide
BE664955A (fr) * 1964-06-05
US3632578A (en) * 1968-09-09 1972-01-04 Lilly Co Eli Cleavage of acylamidocephalosporins and acylamidopenicillins
US3706746A (en) * 1968-11-07 1972-12-19 Ciba Geigy Corp O-desacetyl derivatives of 7-n-acylamino-cephalosphoranic acids
US3632810A (en) * 1968-12-11 1972-01-04 Ciba Geigy Corp Derivatives of 7-amino cephalosporanic acid
GB1350772A (en) * 1971-01-27 1974-04-24 Merck & Co Inc Antibiotics and processes for their production
NL7210941A (fr) * 1971-08-25 1973-02-27

Also Published As

Publication number Publication date
IL41310A0 (en) 1973-03-30
BG22403A3 (bg) 1977-02-20
US3905963A (en) 1975-09-16
CS192502B2 (en) 1979-08-31
CA1014548A (en) 1977-07-26
IE37138L (en) 1973-07-25
DE2303022A1 (de) 1973-08-09
RO62820A (fr) 1977-11-15
JPS4881887A (fr) 1973-11-01
IL41310A (en) 1976-06-30
DE2303022C2 (de) 1984-01-12
ES410946A1 (es) 1976-05-16
GB1409633A (en) 1975-10-08
HU170132B (fr) 1977-04-28
CH567513A5 (fr) 1975-10-15
AU5122673A (en) 1974-07-18
AU465060B2 (en) 1975-09-18
NL7301038A (fr) 1973-07-27
ZA73320B (en) 1974-08-28
IE37138B1 (en) 1977-05-11
PL83446B1 (fr) 1975-12-31
YU20173A (en) 1982-06-18
SE418293B (sv) 1981-05-18
JPS5538956B2 (fr) 1980-10-07
AR196324A1 (es) 1973-12-18
DD103246A5 (fr) 1974-01-12
BE794389A (fr) 1973-07-23
FR2181687A1 (fr) 1973-12-07
ATA57773A (de) 1975-01-15
AT325764B (de) 1975-11-10
YU36973B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
FR2181687B1 (fr)
FR2329924B1 (fr)
JPS4897570U (fr)
CS150890B1 (fr)
CH322372A4 (fr)
CH575470A5 (fr)
CH1809873A4 (fr)
CH315973A4 (fr)
CH586759A5 (fr)
CH557907A (fr)
CH561786A5 (fr)
CH564416A5 (fr)
CH566825A (fr)
CH569167A5 (fr)
CH570503A5 (fr)
CH571764A5 (fr)
CH572351A5 (fr)
CH572363A5 (fr)
CH574595A5 (fr)
CH575207A5 (fr)
CH1626173A4 (fr)
CH1486873A4 (fr)
CH575323A5 (fr)
CH1668773A4 (fr)
CH575509A5 (fr)